Health Canada gives greenlight to cemiplimab-chemo combo for first-line treatment of advanced NSCLC. Early registration for WCLC 23 ends June 9. Read more
Amivantamab Demonstrates Consistent Efficacy in CHRYSALIS Follow-up
Erin JungmeyerSpain’s Dr. Pilar Garrido reviews long-term efficacy, safety, and predictors-of-response data for post-platinum advanced NSCLC patients with EGFR exon 20 insertion mutations. Read more
Early Detection Researcher Shares Epidemiologic Evidence on Air Pollution, Lung Cancer
Erin JungmeyerDr. Christine Berg says both smoking and air pollution are important in causing lung cancer. And both need to be eliminated to help prevent it and save lives. Read more
Analysis Shows Cancer Death Rates Must Decline Faster to Reach ‘Moonshot’ Goal
Erin JungmeyerA team of NCI researchers recently investigated what needs to happen for the United States to reach President Biden’s goal of cutting cancer mortality by 50% by 2047. Read more
Investigator Shares Findings That Point to Possible Mechanism of SCLC Plasticity
Nick IppolitoDuring IASLC’s 2023 Hot Topic Meeting on small cell lung cancer, Dr. Trudy Oliver discussed how MYC genes drive the evolution of SCLC subtypes. Read more
Closing Keynote Highlights Progress, Challenges in Management of SCLC
Nick IppolitoFrom new diagnostic approaches to new evidence on the potential mechanisms of treatment resistance, Dr. Charles M. Rudin looked back on how small cell research has evolved and what needs remain. Read more
Mesothelioma Pioneer Delivers 2023 Heine H. Hansen Keynote Lecture
Nick IppolitoThe Netherlands Cancer Institute’s Dr. Paul Baas was honored for his significant contributions to lung cancer research during the 2023 European Lung Cancer Congress. Read more
Thoracic Oncologists Divided Regarding Role of Neoadjuvant Chemoimmunotherapy
Erin JungmeyerConsensus eluded 2023 European Lung Cancer Congress attendees during a debate on the best approach for NSCLC. Read more
New Texas Lung Cancer Conference Planned with Busy Clinicians in Mind
Erin JungmeyerStephen Liu, MD, and Tina Cascone, MD, PhD, share what attendees can expect at the first ever Texas Lung Cancer Conference, an upcoming two-day CME meeting endorsed by the IASLC. Read more
ILCN Editor Dr. Corey J. Langer Reflects on the ‘Fantastic Voyage’ From Nihilism to Hope in Thoracic Oncology
Nick IppolitoIn addressing fellow TTLC 23 faculty, Dr. Langer recounted the perils and pitfalls, promises and poetry he has experienced in his 35 years in the field. Read more